Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).

  • FEAnalytics.com
  • FEInvest.net
  • FETransmission.com
  • Investegate.co.uk
  • Trustnet.hk
  • Trustnetoffshore.com
  • Trustnetmiddleeast.com

For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.

WHAT INFORMATION DO WE COLLECT ABOUT YOU?

We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.

COOKIES

In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.

HOW WE USE INFORMATION

We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.

ACCESS TO YOUR INFORMATION AND CORRECTION

We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.

WHERE WE STORE YOUR PERSONAL DATA

The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.

CHANGES TO OUR PRIVACY POLICY

Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.

OTHER WEBSITES

Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

CONTACT

If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Avacta Group PLC Ord 10P (AVCT)

Date Time Source Announcement
15 Nov 2017 7:00 am
RNS
Covance to Present Affimer Data at Conference
14 Nov 2017 3:27 pm
RNS
Holding(s) in Company
13 Nov 2017 7:00 am
RNS
Avacta to Present at Investor Evening
  7:00 am
RNS
Avacta to present at PEGS Europe
24 Oct 2017 7:00 am
RNS
Affimers in Scientific Publications
19 Oct 2017 7:00 am
RNS
Private Shareholder Update Event
16 Oct 2017 10:42 am
RNS
Hardman Res.: R&D accelerated to advance assets
12 Oct 2017 7:00 am
RNS
Avacta to Present at Shares Spotlight Evening
10 Oct 2017 7:00 am
RNS
Avacta to Present at Major US Conference
09 Oct 2017 4:02 pm
RNS
Director Dealing and Issue of Equity
05 Oct 2017 7:00 am
RNS
Research collaboration with FIT Biotech Oy
04 Oct 2017 7:00 am
RNS
Preliminary Results
02 Oct 2017 7:00 am
RNS
Avacta establishes US business development team
07 Sep 2017 7:00 am
RNS
Notice of Results
21 Aug 2017 12:00 pm
RNS
Director/PDMR Shareholding
07 Aug 2017 7:00 am
RNS
Trading Update
31 Jul 2017 12:00 pm
RNS
Issue of Equity
28 Jul 2017 1:15 pm
RNS
Director/PDMR Shareholding
05 Jul 2017 7:00 am
RNS
Director Dealing and Issue of Equity
04 Jul 2017 7:00 am
RNS
Manchester ShareSoc Growth Company Seminar
05 Jun 2017 7:00 am
RNS
ShareSoc Growth Company Seminar
01 Jun 2017 8:56 am
RNS
Issue of Equity
22 May 2017 7:00 am
RNS
2 Biotech's Licence Affimers for Research Use
10 May 2017 7:00 am
RNS
Key Affimer Patent To Be Granted in China
08 May 2017 1:21 pm
RNS
Hardman Research: De-risking Moderna's partnership
05 May 2017 7:00 am
RNS
Presenting at the Hardman Private Investor Forum
02 May 2017 7:00 am
RNS
Avacta to Present at BioTrinity 2017
24 Apr 2017 7:00 am
RNS
Diagnostics firm take rights to several Affimers
19 Apr 2017 7:00 am
RNS
Avacta to Present at the Shares Spotlight Evening
12 Apr 2017 7:15 am
RNS
Hardman Research: Another important box ticked
06 Apr 2017 2:23 pm
RNS
Holding(s) in Company
  2:23 pm
RNS
Holding(s) in Company
  10:22 am
RNS
Director/PDMR Shareholding
03 Apr 2017 7:00 am
RNS
Interim Results for the Period Ended 31 Jan 2017
  7:00 am
RNS
Results of Immunogenicity Study with Human Samples
31 Mar 2017 9:31 am
RNS
Avacta Presents at Investor Evening Hosted by TPI
  7:00 am
RNS
London Growth and Innovation Forum Presentation
22 Mar 2017 9:00 am
RNS
Avacta to present at the UK Investor Show
21 Mar 2017 7:15 am
RNS
Hardman Research: Low response would be positive!
30 Jan 2017 7:00 am
RNS
Director/PDMR Shareholding
20 Jan 2017 11:35 am
RNS
Result of Annual General Meeting
  7:00 am
RNS
Trading Update
11 Jan 2017 7:00 am
RNS
Presenting at London Growth and Innovation Forum
05 Jan 2017 7:00 am
RNS
Director Dealing and Issue of Equity
20 Dec 2016 7:00 am
RNS
Director/PDMR Shareholding
16 Dec 2016 5:14 pm
RNS
Holding(s) in Company
01 Dec 2016 7:00 am
RNS
Notice of AGM, Accounts and Directorate Change
23 Nov 2016 7:00 am
RNS
Technical Update: Affinity Separation
07 Nov 2016 7:00 am
RNS
Cancer Expert joins Scientific Advisory Board
02 Nov 2016 7:00 am
RNS
CAR-T Cell Therapy Research Collaboration in US
01 Nov 2016 7:00 am
RNS
Results from first Affimer pre-clinical studies
21 Oct 2016 11:39 am
RNS
Director's Dealing
17 Oct 2016 1:00 pm
RNS
Hardman Research: Great strides to strategic goals
  7:00 am
RNS
Prelim Results for the Year Ended 31 July 2016
04 Oct 2016 3:28 pm
RNS
Issue of Equity
26 Sep 2016 11:21 am
RNS
Notice of Results
22 Sep 2016 7:00 am
RNS
Positive results from first preclinical studies
12 Sep 2016 7:00 am
RNS
Change of Adviser
31 Aug 2016 2:17 pm
RNS
Change of Registered Office
16 Aug 2016 7:00 am
RNS
New Facilities in Cambridge and Wetherby
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t